In the study to establish a LSC score in MDS patients, we previously identified RUNX1, ASXL1 and TP53 mutations correlated with robust LSC character in MDS while SF3B1 mutation, the opposite [11]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.